Sanjay Keswani has left the president and CEO post at Rheos Medicines to become chief medical officer of Annexon Biosciences. Keswani’s experience also includes positions at Roche, Bristol-Myers Squibb (NYSE: BMY), and Eli Lilly (NYSE: LLY). In other moves, South San Francisco-based Annexon named Jennifer Lew chief financial officer and Lesley Stolz chief business officer. Annexon is developing drugs to treat autoimmune and neurodegenerative diseases.
Xconomy Insight · Special Report
Industry experts explain what it takes to launch a new biotech company
From Our Editors · Special Report
The AI, Big Data, and R&D Boom
Sponsored · Webinar
Provide an in vitro drug-induced proarrhythmia assessment & strengthen pharmacological safety profiles of drug candidates
Eurofins DiscoverX
